←Back to Expert Scholars
Translational Medicine / 转化医学Sarcoma, Liposarcoma
Olivier Mir
MD, PhD
🏢Gustave Roussy🌐France
Sarcoma Medical Oncologist
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Olivier Mir leads sarcoma medical oncology trials at Gustave Roussy including European studies of regorafenib and other agents in liposarcoma. His work contributes to EORTC soft tissue sarcoma group efforts. He has published extensively on sarcoma pharmacology.
Share:
🧪Research Fields 研究领域
liposarcoma
sarcoma
regorafenib
clinical trials
EORTC
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Olivier Mir 的研究动态
Follow Olivier Mir's research updates
留下邮箱，当我们发布与 Olivier Mir（Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment